1. Home
  2. AMPL vs CMPX Comparison

AMPL vs CMPX Comparison

Compare AMPL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$6.67

Market Cap

864.7M

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.06

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
CMPX
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
864.7M
927.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AMPL
CMPX
Price
$6.67
$2.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
9
Target Price
$13.42
$14.57
AVG Volume (30 Days)
2.5M
12.8M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
N/A
EPS
N/A
N/A
Revenue
$343,214,000.00
N/A
Revenue This Year
$17.43
N/A
Revenue Next Year
$14.16
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
14.68
N/A
52 Week Low
$5.51
$1.61
52 Week High
$14.27
$6.88

Technical Indicators

Market Signals
Indicator
AMPL
CMPX
Relative Strength Index (RSI) 49.99 34.36
Support Level $6.43 $1.61
Resistance Level $7.73 $3.54
Average True Range (ATR) 0.39 0.14
MACD -0.00 0.13
Stochastic Oscillator 43.19 78.75

Price Performance

Historical Comparison
AMPL
CMPX

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: